Answers are grounded in this paper and cite their sources.
The Xpert Flu/RSV XC assay was compared to laboratory-developed tests (LDTs) (n = 207) and the Xpert Flu assay (n = 147) using archived nasopharyngeal swabs. The percentages of positive agreements with LDTs were 97.8% for influenza A, 97.2% for influenza B, and 89.3% for RSV. The sensitivity of influenza detection was improved with the Xpert Flu/RSV XC assay compared to the Xpert Flu assay.
No takes yet. Share an insight, caveat, or question.
Popowitch et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: